Search clinical trials for: NIS793
Total 9 results
-
Novartis PharmaceuticalsActive, not recruitingMyelodysplastic SyndromesUnited States, Spain, Italy, Singapore, Korea, Republic of, Israel, Australia
-
Novartis PharmaceuticalsActive, not recruitingMyelofibrosisUnited Kingdom, Australia, Canada, Switzerland, Netherlands, Spain, Germany, Italy, Turkey, Russian Federation, Sweden, Denmark, Hungary
-
Novartis PharmaceuticalsCompletedBreast Cancer | Colorectal Cancer | Pancreatic Cancer | Lung Cancer | Renal Cancer | Hepatocellular CancerTaiwan, Germany, Italy, Austria, Switzerland, Hong Kong, Japan, Canada, United States
-
Novartis PharmaceuticalsWithdrawnPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia Vera Myelofibrosis | PMF | Post-Essential Thrombocythemia Myelofibrosis
-
Novartis PharmaceuticalsActive, not recruitingMetastatic Pancreatic Ductal AdenocarcinomaUnited States, China, Hungary, Taiwan, Belgium, Germany, Spain, Italy, Czechia, France, Japan, Switzerland, Australia, Israel, Korea, Republic of, Canada, Russian Federation, Slovakia, United Kingdom, Turkey, Sweden, Greece, Finland, ... and more
-
Novartis PharmaceuticalsActive, not recruitingMetastatic Pancreatic Ductal AdenocarcinomaBelgium, Taiwan, Australia, Germany, Spain, Italy, Austria, Czechia, Switzerland, Singapore, United Kingdom, Finland, United States, France
-
Novartis PharmaceuticalsActive, not recruitingMetastatic Colorectal CancerCanada, Taiwan, Belgium, Germany, Spain, Italy, Czechia, Switzerland, Australia, United States, Japan, Singapore, United Kingdom, France, Israel, Hong Kong, Korea, Republic of
-
Kimberly Perez, MDNovartisTerminatedPancreatic Cancer | Pancreatic Adenocarcinoma | Resectable Pancreatic Cancer | Borderline Resectable Pancreatic AdenocarcinomaUnited States
-
Colin D. Weekes, M.D.NovartisRecruitingPancreas Cancer | Metastatic Pancreatic Adenocarcinoma | Metastatic Pancreatic CancerUnited States